US Stock MarketDetailed Quotes

ASMB Assembly Biosciences

Watchlist
  • 11.010
  • +0.320+2.99%
Close Mar 21 16:00 ET
  • 11.220
  • +0.210+1.91%
Post 16:14 ET
82.61MMarket Cap-1.65P/E (TTM)

Assembly Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-324.76%-51.12M
-100.55%-407K
-10.08%-15.24M
-25.49%-17.1M
21.62%-18.36M
126.93%22.74M
482.50%73.65M
30.14%-13.85M
23.80%-13.63M
14.81%-23.43M
Net income from continuing operations
34.38%-40.18M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
Operating gains losses
----
----
----
----
----
--139K
----
----
----
----
Depreciation and amortization
-71.33%129K
-61.90%32K
-71.55%33K
-74.60%32K
-74.19%32K
-9.64%450K
-32.26%84K
-13.43%116K
5.00%126K
3.33%124K
Other non cash items
-59.60%1.42M
-64.05%353K
-56.99%351K
-58.55%354K
-58.01%359K
0.06%3.51M
14.05%982K
-5.12%816K
-4.15%854K
-4.26%855K
Change In working capital
-115.65%-11.95M
-88.76%9.39M
-405.16%-5.97M
-590.06%-6.21M
-26.42%-9.15M
3,697.60%76.34M
37,510.81%83.5M
-256.97%-1.18M
-67.67%1.27M
-3.19%-7.24M
-Change in receivables
-95.23%43K
--0
--0
-88.53%43K
--0
248.19%901K
-114.24%-43K
147.30%342K
37,400.00%375K
220.74%227K
-Change in prepaid assets
-92.03%73K
-371.43%-165K
1.57%453K
-79.22%437K
59.20%-652K
-31.02%916K
95.22%-35K
-76.54%446K
1,129.82%2.1M
-13,216.67%-1.6M
-Change in payables and accrued expense
145.03%2.63M
145.95%2.03M
188.57%767K
805.76%2.08M
59.08%-2.25M
-41,814.29%-5.84M
-2.82%827K
-290.75%-866K
-107.14%-295K
-1.57%-5.51M
-Change in other current assets
--0
--0
--0
--0
--0
-29.12%577K
-66.85%240K
-1,100.00%-220K
-99.63%2K
217.58%555K
-Change in other current liabilities
62.90%-1.4M
66.51%-353K
60.86%-346K
74.07%-238K
49.56%-463K
-2.83%-3.77M
-14.19%-1.05M
1.89%-884K
0.54%-918K
0.54%-918K
-Change in other working capital
-115.91%-13.29M
--7.87M
---6.85M
---8.53M
---5.79M
--83.56M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-324.76%-51.12M
-100.55%-407K
-10.08%-15.24M
-25.49%-17.1M
21.62%-18.36M
126.93%22.74M
482.50%73.65M
30.14%-13.85M
23.80%-13.63M
14.81%-23.43M
Investing cash flow
Cash flow from continuing investing activities
158.10%40.17M
92.53%-6.7M
29.70%24.49M
161.05%5.11M
72.72%17.27M
-176.28%-69.14M
-641.32%-89.65M
-39.93%18.88M
-187.16%-8.37M
-69.74%10M
Net PPE purchase and sale
87.88%-28K
--0
--0
70.83%-14K
---14K
-126.47%-231K
---47K
-33.33%-136K
---48K
--0
Net investment purchase and sale
158.34%40.2M
92.53%-6.7M
28.77%24.49M
161.57%5.12M
72.86%17.29M
-177.21%-68.91M
-694.92%-89.61M
-39.69%19.02M
-186.66%-8.32M
-69.74%10M
Cash from discontinued investing activities
Investing cash flow
158.10%40.17M
92.53%-6.7M
29.70%24.49M
161.05%5.11M
72.72%17.27M
-176.28%-69.14M
-641.32%-89.65M
-39.93%18.88M
-187.16%-8.37M
-69.74%10M
Financing cash flow
Cash flow from continuing financing activities
113.12%29.45M
84.89%17M
0
9,194.03%12.45M
0
2,150.49%13.82M
2,003.43%9.19M
0
-24.29%134K
4.49M
Net common stock issuance
114.00%29.29M
84.83%16.9M
--0
22,853.70%12.4M
--0
4,112.00%13.69M
2,713.23%9.14M
--0
--54K
--4.49M
Proceeds from stock option exercised by employees
20.16%155K
95.92%96K
--0
----
----
-55.36%129K
-56.25%49K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
113.12%29.45M
84.89%17M
--0
9,194.03%12.45M
--0
2,150.49%13.82M
2,003.43%9.19M
--0
-24.29%134K
--4.49M
Net cash flow
Beginning cash position
-62.15%19.84M
6.74%28.45M
-11.17%19.21M
-56.88%18.75M
-62.15%19.84M
14.88%52.42M
-51.24%26.66M
-49.79%21.62M
-15.03%43.48M
14.88%52.42M
Current changes in cash
156.80%18.5M
245.15%9.89M
83.67%9.24M
102.10%459K
87.78%-1.09M
-579.71%-32.58M
-202.22%-6.82M
-56.65%5.03M
-169.50%-21.86M
-261.10%-8.94M
End cash Position
93.26%38.34M
93.26%38.34M
6.74%28.45M
-11.17%19.21M
-56.88%18.75M
-62.15%19.84M
-62.15%19.84M
-51.24%26.66M
-49.79%21.62M
-15.03%43.48M
Free cash flow
-327.43%-51.15M
-100.55%-407K
-9.01%-15.24M
-25.15%-17.12M
21.56%-18.38M
126.59%22.49M
482.13%73.58M
29.81%-13.98M
23.53%-13.68M
14.81%-23.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -324.76%-51.12M-100.55%-407K-10.08%-15.24M-25.49%-17.1M21.62%-18.36M126.93%22.74M482.50%73.65M30.14%-13.85M23.80%-13.63M14.81%-23.43M
Net income from continuing operations 34.38%-40.18M5.72%-10.34M33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M
Operating gains losses ----------------------139K----------------
Depreciation and amortization -71.33%129K-61.90%32K-71.55%33K-74.60%32K-74.19%32K-9.64%450K-32.26%84K-13.43%116K5.00%126K3.33%124K
Other non cash items -59.60%1.42M-64.05%353K-56.99%351K-58.55%354K-58.01%359K0.06%3.51M14.05%982K-5.12%816K-4.15%854K-4.26%855K
Change In working capital -115.65%-11.95M-88.76%9.39M-405.16%-5.97M-590.06%-6.21M-26.42%-9.15M3,697.60%76.34M37,510.81%83.5M-256.97%-1.18M-67.67%1.27M-3.19%-7.24M
-Change in receivables -95.23%43K--0--0-88.53%43K--0248.19%901K-114.24%-43K147.30%342K37,400.00%375K220.74%227K
-Change in prepaid assets -92.03%73K-371.43%-165K1.57%453K-79.22%437K59.20%-652K-31.02%916K95.22%-35K-76.54%446K1,129.82%2.1M-13,216.67%-1.6M
-Change in payables and accrued expense 145.03%2.63M145.95%2.03M188.57%767K805.76%2.08M59.08%-2.25M-41,814.29%-5.84M-2.82%827K-290.75%-866K-107.14%-295K-1.57%-5.51M
-Change in other current assets --0--0--0--0--0-29.12%577K-66.85%240K-1,100.00%-220K-99.63%2K217.58%555K
-Change in other current liabilities 62.90%-1.4M66.51%-353K60.86%-346K74.07%-238K49.56%-463K-2.83%-3.77M-14.19%-1.05M1.89%-884K0.54%-918K0.54%-918K
-Change in other working capital -115.91%-13.29M--7.87M---6.85M---8.53M---5.79M--83.56M----------------
Cash from discontinued investing activities
Operating cash flow -324.76%-51.12M-100.55%-407K-10.08%-15.24M-25.49%-17.1M21.62%-18.36M126.93%22.74M482.50%73.65M30.14%-13.85M23.80%-13.63M14.81%-23.43M
Investing cash flow
Cash flow from continuing investing activities 158.10%40.17M92.53%-6.7M29.70%24.49M161.05%5.11M72.72%17.27M-176.28%-69.14M-641.32%-89.65M-39.93%18.88M-187.16%-8.37M-69.74%10M
Net PPE purchase and sale 87.88%-28K--0--070.83%-14K---14K-126.47%-231K---47K-33.33%-136K---48K--0
Net investment purchase and sale 158.34%40.2M92.53%-6.7M28.77%24.49M161.57%5.12M72.86%17.29M-177.21%-68.91M-694.92%-89.61M-39.69%19.02M-186.66%-8.32M-69.74%10M
Cash from discontinued investing activities
Investing cash flow 158.10%40.17M92.53%-6.7M29.70%24.49M161.05%5.11M72.72%17.27M-176.28%-69.14M-641.32%-89.65M-39.93%18.88M-187.16%-8.37M-69.74%10M
Financing cash flow
Cash flow from continuing financing activities 113.12%29.45M84.89%17M09,194.03%12.45M02,150.49%13.82M2,003.43%9.19M0-24.29%134K4.49M
Net common stock issuance 114.00%29.29M84.83%16.9M--022,853.70%12.4M--04,112.00%13.69M2,713.23%9.14M--0--54K--4.49M
Proceeds from stock option exercised by employees 20.16%155K95.92%96K--0---------55.36%129K-56.25%49K--0--------
Cash from discontinued financing activities
Financing cash flow 113.12%29.45M84.89%17M--09,194.03%12.45M--02,150.49%13.82M2,003.43%9.19M--0-24.29%134K--4.49M
Net cash flow
Beginning cash position -62.15%19.84M6.74%28.45M-11.17%19.21M-56.88%18.75M-62.15%19.84M14.88%52.42M-51.24%26.66M-49.79%21.62M-15.03%43.48M14.88%52.42M
Current changes in cash 156.80%18.5M245.15%9.89M83.67%9.24M102.10%459K87.78%-1.09M-579.71%-32.58M-202.22%-6.82M-56.65%5.03M-169.50%-21.86M-261.10%-8.94M
End cash Position 93.26%38.34M93.26%38.34M6.74%28.45M-11.17%19.21M-56.88%18.75M-62.15%19.84M-62.15%19.84M-51.24%26.66M-49.79%21.62M-15.03%43.48M
Free cash flow -327.43%-51.15M-100.55%-407K-9.01%-15.24M-25.15%-17.12M21.56%-18.38M126.59%22.49M482.13%73.58M29.81%-13.98M23.53%-13.68M14.81%-23.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Microsoft
MSFT
+1.14%
Petroleo Brasileiro SA Petrobras
PBR
+0.93%

Unlock the Full List